PATENT CLAIM ANALYSIS

Application Number: 16166292
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["435", "007920"]

Abstract:
Certain embodiments are directed to method of measuring fortilin in a serum sample as a biomarker of in vivo apoptosis, which can be utilized to noninvasively assess the status of in vivo apoptosis in a subject.

Claim (Index 8):
The method of  claim 5 , wherein the subject is a human.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 97.0
- Lexical Diversity: 1.35714
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10021753', '12511478', '13443462', '15257669', '12515770']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5930708634688366
- 35 USC 102 Novelty (BERT): 0.4886208717438091
- Combined Prediction Score: 0.5826258642963339
- Mean Citation Score: 217.698576
- Max Citation Score: 242.66211
- Similarity Product: 199.87478014967323

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test